Our Company

Robert Taylor, MD, PhD

Member
ObsEva Scientific Advisory Board

Obstetrician and Gynecologist, Reproductive Endocrinologist, Professor and Vice Chair for Research, Wake Forest School of Medicine, Winston-Salem, North Carolina USA.

Robert Taylor received his undergraduate education at Stanford University and the combined MD-PhD at Baylor College of Medicine, where he studied the molecular biology of estrogen action. He was a resident and fellow in Reproductive Endocrinology at the University of California, San Francisco and a post-doctoral scholar in the Howard Hughes Medical Institute at UCSF. He served on the medical faculty at UCSF from 1987-2005, at Emory School of Medicine from 2005-2011, and at Wake Forest since 2011. His clinical and translational research interests include the molecular actions of estrogen and progesterone on endometrial differentiation and vascularization, the pathogenesis of endometriosis and the regulation of placental angiogenesis in preeclampsia and other pregnancy complications.

Are you sure you want to leave ObsEva.com?

We’re sorry to see you go. Choose one of the following actions to stay on the site or leave.

Continue to link

Disclaimer

Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

Continue

Disclaimer

Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

Continue